Age (years), mean ± SD | 61.68 ± 16.54 |
---|---|
Sex, n (%) | |
Male | 8 (25.81) |
Female | 23 (74.19) |
Tumor location, n (%) | |
Trunk | 2 (6.45) |
Head and neck | 7 (22.58) |
Extremity | 22 (70.97) |
Lymph node metastases, n (%) | |
Present | 21 (67.74) |
Absent | 10 (32.26) |
Breslow thickness | |
≤ 4.00 mm | 2 (6.45) |
> 4.00 mm | 29 (93.55) |
Necrosis, n (%) | |
Present | 23 (74.19) |
Absent | 8 (25.81) |
Tumor diameter (mm), mean ± SD | 30.00 ± 24.09 |
Ulceration | |
Present | 16 (51.61) |
Absent | 15 (48.39) |
Tumor-infiltrating lymphocytes | |
Present (brisk and non-brisk) | 23 (74.19) |
Absent | 8 (25.81) |
Clinical stage | |
I | 0 (0.00) |
II | 9 (29.03) |
III | 11 (35.48) |
IV | 11 (35.48) |
Survival status | |
Alive | 7 (22.58) |
Deceased | 24 (77.42) |
Overall survival (months), mean ± SD | 22.84 ± 15.75 |